Novartis taps Euro for Elidel, Lamisil med ed

Share this article:

Novartis has tapped Euro RSCG Life to handle its global Elidel medical education business following a competitive pitch against several unknown agencies. The Havas network will also take on project work for Lamisil med ed.
The global medical education assignment for Novartis' dermatology franchise, including both Elidel and Lamisil, was previously handled by London-based Parthenon Medical Communications, a division of Boca Raton, Fla. publisher CRC Press' U.K. imprint, Parthenon Publishing.
Work on the accounts will target both primary care and specialty physicians, and will be handled out of Euro RSCG Life's London office and led by Cliff Wyatt, president, medical education Europe.
Euro RSCG Life, MM&M's Network of the Year for 2004, was named a preferred vendor on Novartis' global medical education business last year.

Share this article:

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.